Site içinde arama yapın | Ifvex

Ifvex

bir ses eklendi Health
2025-10-03 04:39:34 -

Singapore’s ClavystBio backs UK biotech Cirrus Therapeutics’s $11M funding
Cirrus Therapeutics, an United Kingdom-based ocular immunology-focused biotech, announced Wednesday the close of an $11 million seed financing to advance its pipeline of gene and cell therapies aimed at improving quality of life and extending the ocular healthspan of patients with chronic blinding diseases. The round was led by ClavystBio, with participation from Polaris Partners and SEEDS,...

0 Yorumlar 0 hisse senetleri 623 Views 0 önizleme

Please log in to like, share and comment!
Ifvex

bir ses eklendi Health
2025-05-09 14:00:50 -

Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing. The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund,...

0 Yorumlar 0 hisse senetleri 9K Views 0 önizleme

Please log in to like, share and comment!

Sponsorluk

Ifvex https://ifvex.com